97. 潰瘍性大腸炎
[臨床試験数:2,269,薬物数:1,331(DrugBank:241),標的遺伝子数:114,標的パスウェイ数:181

Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03773952
(ClinicalTrials.gov)
July 1, 201830/11/2018Safety and Efficacy of PBF-677 in Ulcerative Colitis PatientsA Phase IIa (Proof of Concept), Randomized, Double Blind, Placebo Controlled, Multicenter Clinical Trial to Evaluate the Safety and Efficacy of Oral Treatment With PBF-677 in Patients With Mild to Moderate Ulcerative ColitisUlcerative ColitisDrug: PBF-677;Drug: Placebo oral capsulePalobiofarma SLQualitecfarmaRecruiting18 Years75 YearsAll50Phase 2Spain
2EUCTR2017-003228-54-ES
(EUCTR)
28/05/201809/04/2018A clinical trial to evaluate the safety and efficacy of oral treatment with PBF-677 in patients with mild to moderate ulcerative colitis.A Phase IIa (proof of concept), randomized, double blind, placebo controlled, multicenter clinical trial to evaluate the safety and efficacy of oral treatment with PBF-677 in patients with mild to moderate ulcerative colitis. Inflammatory Bowel disease, mild to moderate Ulcerative Colitis;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]Product Code: PBF-677
INN or Proposed INN: PBF-677
PaloBiofarma S.L.NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
30Phase 2Spain